Vanberra Signal
Free trial

Moleculern

Curated by Signal

Provider of AI-powered drug discovery platform and data-driven models to accelerate the development of new medicines

Health Technologymoleculern.com

Overview

Provider of AI-powered drug discovery platform and data-driven models to accelerate the development of new medicines. It offers technology that combines biology and chemistry with modern machine learning capabilities to rapidly identify potential drug targets and develop treatments. It offers compound library including physical and virtual synthesis-ready fragments and NCEs, to identify lead molecules targeting any class of protein.

Key facts

Founded
2024
Headquarters
Lehi, United States
Stage
Sign up to view
Industry
Health Technology

Business model

3 products and services
Sign up to view

Contact

Email
Sign up to view
Phone
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • Herbals for Athletes

    Online retailer of nutritional supplements, essential oils, and other healthcare products

    Health TechnologyUnited States

  • CMES

    Provider of a cloud-based educational platform for healthcare professionals

    Health TechnologyNorthumberland, United States

  • MermsEMR

    Provider of practice management and EHR solutions

    Health TechnologyAtlanta, United States

About Moleculern

What does Moleculern do?

Provider of AI-powered drug discovery platform and data-driven models to accelerate the development of new medicines.

Where is Moleculern headquartered?

Moleculern is headquartered in Lehi, United States.

When was Moleculern founded?

Moleculern was founded in 2024.

Which sector is Moleculern in?

Moleculern operates in Health Technology.

Who are Moleculern's competitors?

Companies similar to Moleculern include Herbals for Athletes, CMES, and MermsEMR.